Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sales of pharmaceutical products in China. The company pro...
A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%
Luoxin Pharmaceutical: The controlling shareholder has partially lifted the pledge of shares and re-pledged them
Luoxin Pharmaceutical: Net profit in the third quarter was 5.2318 million yuan, a year-on-year increase of 102.96%
The concept of innovative drugs continues to rebound, with GZBL and Luoxin Pharmaceutical both hitting the daily limit
Luoxin Pharmaceutical issued a profit warning, expecting a net profit attributable to the parent company of 22.7 million to 25.2 million yuan in the first three quarters, turning losses into profits
Luoxin Pharmaceutical: Han Fengsheng resigns as board secretary, Jiang Ying takes over